Home About us Contact
|
Home About us Contact | ||
|
|
||
Dimeric Compound (dimeric + compound)
Selected AbstractsChemInform Abstract: Formation and Structures of Dimeric Compounds from an (E)-5,5,-Diphenyl-2,2,,3,3,-tetrahydro-3,3,-bipyrrolylidene-2,2,-dione.CHEMINFORM, Issue 26 2001Hajime Irikawa Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a "Full Text" option. The original article is trackable via the "References" option. [source] Bis(phosphinimino)methanides as Ligands in Divalent Samarium Chemistry: Synthesis, Structures and CatalysisEUROPEAN JOURNAL OF INORGANIC CHEMISTRY, Issue 6 2007Michal Wiecko Abstract The reaction of K{CH(PPh2NSiMe3)2} with samarium diiodide in a 1:1 molar ratio in thf affords the corresponding divalent samarium complex [{(Me3SiNPPh2)2CH}Sm(,-I)(thf)]2 (1), whereas treatment of K{CH(PPh2NSiMe3)2} with samarium diiodide in a 2:1 molar ratio in thf gives the homoleptic complex [{(Me3SiNPPh2)2CH}2Sm] (2). When 1 is treated with KNPh2 in toluene in a 2:1 molar ratio the mixed dimeric compound [({(Me3SiNPPh2)CH}2Sm)2(,-I)(,-NPh2)] (3) is obtained. The single-crystal X-ray structures of all these complexes have been determined. [{(Me3SiNPPh2)2CH}Sm(,-I)(thf)]2 has also been successfully used as a catalyst for the polymerization of ,-caprolactone. Good activities and molecular masses are observed with this catalyst.(© Wiley-VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2007) [source] Synthesis and Reaction of MnII Iodides Bearing the ,-Diketiminate Ligand: the First Divalent Manganese N-Heterocyclic Carbene Complexes [{HC(CMeNAr)2}MnI{C[N(iPr)CMe]2}] and [{HC(CMeNAr)2}MnNHAr{C[N(iPr)CMe]2}] (Ar = 2,6- iPr2C6H3)EUROPEAN JOURNAL OF INORGANIC CHEMISTRY, Issue 24 2003Jianfang Chai Abstract The manganese mono-iodide [HC(CMeNAr)2]MnI(THF) (Ar = 2,6- iPr2C6H3) (3) was prepared in good yield from the reaction of [HC(CMeNAr)2]K with MnI2 in THF. Treatment of 3 under reflux in toluene and removing all the volatiles in vacuo afforded the dimeric compound [{HC(CMeNAr)2}Mn]2(,-I)2 (4). Displacement of the coordinated THF in 3 by a strong Lewis base C[N(iPr)CMe]2 or by adding C[N(iPr)CMe]2 to the toluene solution of 4 readily gave the N-heterocyclic carbene adduct [{HC(CMeNAr)2}]MnI{C[N(iPr)CMe]2} (5). Reduction of 5 with sodium/potassium alloy at room temperature unexpectedly resulted in the formation of the monomeric compound [{HC(CMeNAr)2}]MnNHAr{C[N(iPr)CMe]2} (6). Alternatively 6 was obtained by the salt elimination reaction of 5 with LiNHAr. Compounds 5 and 6 are the first examples of divalent manganese N-heterocyclic carbene adducts and the first manganese non-carbonyl carbene complexes. The single crystal X-ray structural analyses reveal that compounds 3 and 6 are monomeric and compound 4 is dimeric in the solid state. The manganese centers in these compounds exhibit a distorted tetrahedral geometry. (© Wiley-VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2003) [source] Aminoglycoside,Quinacridine Conjugates: Towards Recognition of the P6.1 Element of Telomerase RNACHEMBIOCHEM, Issue 2 2006Markus Kaiser Dr. Abstract A modular synthesis has been developed which allows easy and rapid attachment of one or two aminoglycoside units to a quinacridine intercalator, thereby leading to monomeric and dimeric conjugates. Melting temperature (Tm) experiments show that the tobramycin dimeric conjugate TD1 exhibits strong binding to the P6.1 element of human telomerase RNA. By contrast, tobramycin alone is much less efficient and the monomeric compound TM1 elicits a poor binding ability. Monitoring of the interaction by an electrophoretic mobility shift assay shows a 1:1 stoichiometry for the binding of the dimeric compound to the hairpin structure and confirms the lower affinity for a control duplex. Protection experiments with RNase T1 indicate interaction of the drug both in the stem and in the loop of the hairpin. Taken together, the data suggest a binding of TD1 inside the hairpin at the stem-loop junction. The same trends are observed with paromomycin and kanamycin analogues but with a lower affinity. [source] Synthesis of Dimeric Quinazolin-2-one, 1,4-Benzodiazepin-2-one, and Isoalloxazine Compounds as Inhibitors of Amyloid Peptides AssociationARCHIV DER PHARMAZIE, Issue 8 2009Alexander Barthel Abstract The synthesis of dimeric compounds derived from quinazolin-2-one and 1,4-benzodiazepin-2-one possessing a piperazine or homopiperazine spacer was investigated. In addition, a piperazine spacered bis-isoalloxazine and a bis-riboflavin compound were prepared and their ability to interrupt the association of prion proteins and Alzheimer-specific A, peptides was investigated using a fast screening system based on flow cytometry. The bis-isoalloxazine 14 was identified as a new lead structure. [source] Synthesis and Pharmacological Evaluation of Dimeric Follicle-Stimulating Hormone Receptor AntagonistsCHEMMEDCHEM, Issue 12 2009Kimberly Abstract A series of homo- and heterodimeric compounds encompassing the follicle-stimulating hormone receptor (FSHR) antagonist (R)- 1 and its inactive conformer (S)- 1 connected through ethylene glycol spacers of various lengths is described. Evaluation of these compounds reveals that dimeric compounds, with a spacer of sufficient length, bearing two active copies of the antagonist are more potent relative to dimeric compounds in which one of the active pharmacophores is replaced by an inactive conformer. Interestingly, the opposite trend is observed if a short spacer is used, indicating that these compounds may be valuable tools to study FSHR dimerization in greater detail. [source] | ||||||||||